Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Recent developments in cell-based immune therapy for neuroblastoma.

Recent developments in cell-based immune therapy for neuroblastoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Recent developments in cell-based immune therapy for neuroblastoma. Abstract Text:

    michael r vernerisMichael R Verneris,john e wagnerJohn E Wagner,

    Neuroblastoma (NB) is a common and aggressive tumor of early childhood. To date, treatment with chemotherapy, surgery, and radiation therapy has resulted in suboptimal outcomes in those with advanced disease. Immune-based treatments hold promise for patients with recurrent or advanced NB. Here, recent preclinical studies and early stage (phase I) clinical trials using cellular therapeutic approaches for NB are reviewed, including studies of natural killer cells, gammadelta T cells, chimeric receptor expressing T cells, dendritic cells, and allogeneic hematopoietic cell transplant.

    Recent developments in cell-based immune therapy for neuroblastoma. Publishing Authors By Initials

    mr vernerisMR Verneris,je wagnerJE Wagner,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Recent developments in cell-based immune therapy for neuroblastoma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of neuroimmune pharmacology : the official

    VOLUME: 2

    Page Numbers: 134-9

    Journal Abbreviation:

    ISSN: 1557-1904

    DAY: 2

    MONTH: 03

    YEAR: 2007

    Recent developments in cell-based immune therapy for neuroblastoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101256586

    Recent developments in cell-based immune therapy for neuroblastoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Recent developments in cell-based immune therapy for neuroblastoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Recent developments in cell-based immune therapy for neuroblastoma.

    AFFILIATION: Blood and Marrow Transplant Program, Department of Pediatrics, University of Minnesota, Mayo Mail Code 366, 420 Delaware Street, S.E., Minneapolis, MN 55455, USA. verneris@umn.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Neuroimmune Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Recent developments in cell-based immune therapy for neuroblastoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News